MD
Pediatrix Medical Group, Inc.NYSEHealthcare$21.18+2.32%ClosedMarket Cap: $1.76B
As of 2026-04-06
Valuation
P/E (TTM)
10.64
PEG
0.04
P/B
2.11
P/S
0.94
EV/EBITDA
7.78
DCF Value
$27.20
FCF Yield
14.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
25.5%
Operating Margin
11.2%
Net Margin
8.6%
ROE
19.6%
ROA
7.4%
ROIC
9.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $493.8M | 24.4% | $54.7M | $33.7M | $0.40 | — |
| FY 2025 | $1.91B | 24.7% | $231.1M | $165.4M | $1.94 | — |
| Q3 2025 | $492.9M | 28.5% | $68.1M | $71.7M | $0.84 | — |
| Q2 2025 | $468.8M | 26.6% | $59.9M | $39.3M | $0.45 | — |
| Q1 2025 | $458.4M | 22.4% | $32.1M | $20.7M | $0.24 | — |
| Q4 2024 | $502.4M | 25.6% | $39.3M | $30.5M | $0.35 | — |
| FY 2024 | $2.01B | 22.6% | $-68.7M | $-99.1M | $-1.19 | — |
| Q3 2024 | $511.2M | 22.9% | $33.8M | $19.4M | $0.23 | — |
| Q2 2024 | $504.3M | 22.6% | $-157.7M | $-153.0M | $-1.84 | — |
| Q1 2024 | $495.1M | 19.2% | $15.9M | $4.0M | $0.05 | — |
| Q4 2023 | $496.4M | 20.4% | $-111.5M | $-124.3M | $-1.50 | — |
| FY 2023 | $1.99B | 21.1% | $7.3M | $-60.4M | $-0.73 | — |